Unlock instant, AI-driven research and patent intelligence for your innovation.

Oral solution for treatment of viral myocarditis of child

A viral myocarditis, oral liquid technology, applied in the direction of antiviral agents, cardiovascular system diseases, medical preparations containing active ingredients, etc. , significant curative effect, good curative effect

Inactive Publication Date: 2013-01-30
李润芝
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there has been a lack of effective drugs for the treatment of myocarditis and cardiomyopathy at home and abroad, and the effect of western medicine is not satisfactory. Generally, it can only treat the symptoms but not the root cause: myocardial nutrition and metabolic drugs (such as vitamins, coenzyme Ql0, and muscle supplements) as nutritional supplements; or use immunotherapy as appropriate. Biological agents, but these drugs themselves may also directly cause myocardial immune damage and cold symptoms, with prominent side effects and high prices, often delaying the disease, and even leading to aggravation of the disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Embodiment 1 prepares the oral liquid for the treatment of children's viral myocarditis

[0016] The formula is: 30 grams of Astragalus, 30 grams of Scrophulariae, 30 grams of Cortex Phellodendri, 20 grams of Yuanhu, 20 grams of Suanzaoren, 20 grams of Poria, 20 grams of Polygala, 10 grams of lotus seed heart, 10 grams of fried Atractylodes macrocephala, 10 grams of Schisandra chinensis (one agent).

[0017] The preparation method is as follows: take the raw materials, mix them, add water to decoct for 1.5 hours, filter to obtain the filtrate, add water to the filter residue and decoct for 1 hour, filter to obtain the filtrate, combine the two filtrates, and concentrate to a relative density of 1.22-1.24 (50°C ), namely the oral solution for the treatment of viral myocarditis.

Embodiment 2

[0018] Embodiment 2 prepares the oral liquid for the treatment of children's viral myocarditis

[0019] The formula is: 28 grams of Astragalus, 28 grams of Scrophulariae, 32 grams of Cortex Phellodendri, 22 grams of Yuanhu, 18 grams of Suanzaoren, 18 grams of Poria, 22 grams of Polygala, 13 grams of lotus seed heart, 8 grams of fried Atractylodes macrocephala, and 8 grams of Schisandra chinensis.

[0020] The preparation method is as follows: take the raw materials, mix them, add water to decoct for 1.5 hours, filter to obtain the filtrate, add water to the filter residue and decoct for 1 hour, filter to obtain the filtrate, combine the two filtrates, and concentrate to a relative density of 1.22-1.24 (50°C ), that is.

Embodiment 3

[0021] Embodiment 3 prepares the oral liquid for the treatment of children's viral myocarditis

[0022] The formula is: 32 grams of Astragalus, 32 grams of Scrophulariae, 28 grams of Cortex Phellodendri, 18 grams of Yuanhu, 22 grams of Suanzaoren, 22 grams of Poria, 18 grams of Polygala, 8 grams of lotus seed heart, 13 grams of fried Atractylodes macrocephala, and 13 grams of Schisandra chinensis.

[0023] The preparation method is as follows: take the raw materials, mix them, add water to decoct for 1.5 hours, filter to obtain the filtrate, add water to the filter residue and decoct for 1 hour, filter to obtain the filtrate, combine the two filtrates, and concentrate to a relative density of 1.22-1.24 (50°C ), that is.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses oral solution for treatment of viral myocarditis of a child. The oral solution is prepared with the following raw materials: 25-35g of astragalus mongholicus, 25-35g of radix scrophulariae, 25-35g of cortex phellodendri, 15-25g of rhizoma corydalis, 15-25g of spina date seed, 15-25g of poria cocos, 15-25g of polygala tenuifolia, 5-15g of lotus plumule, 5-15g of fried rhizoma atractylodis macrocephalae and 5-15g of fructus schisandrae. A preparation method comprises the following steps of: taking raw materials, mixing, adding water, decocting for 1-2 hours, filtering to obtain filtrate, adding water into the filtrate, decocting the filtrate for 0.5-1.5 hours, filtering to obtain filtrate, mixing the two types of filtrate, and concentrating until the relative density is 1.22-1.24 (50 DEG C), thereby obtaining the oral solution. The solution is taken orally twice a day when being applied for treatment. Generally, viral myocarditis can be cured in approximately one month. The oral solution for treatment of viral myocarditis of the child has the advantages of significant and rapid curative effects and no toxic or side effects, and the total efficacy can reach 97.5 percent.

Description

technical field [0001] The invention relates to an oral liquid for treating children's viral myocarditis. Background technique [0002] Viral myocarditis ((VMC) is a common and frequently-occurring disease of the cardiovascular system, and it is also one of the main causes of dilated cardiomyopathy, heart failure and comminuted death. At present, no matter in developed countries or in developing countries, the incidence of myocarditis The rate has significantly increased compared with 10 years ago, which is mainly due to the increased incidence of viral myocarditis in infectious myocarditis. According to the World Health Organization (WHO) global virus surveillance research report: sudden death cases in newborns and children Among them, 20% are caused by viral myocarditis; the incidence rate of viral myocarditis in newborns and children is 360 / 100,000, and the mortality rate is 8%. After viral infection invades the myocardium, it will cause focal or diffuse myocarditis Inte...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/808A61K9/08A61P9/04A61P31/12
Inventor 李润芝
Owner 李润芝